Skip to main content
Premium Trial:

Request an Annual Quote

InformedDNA to Provide Genetic Counseling for Cigna Members

NEW YORK (GenomeWeb News) – InformedDNA today said that it is providing genetic counseling to certain members of health plan Cigna.

St. Petersburg, Fla.-based InformedDNA is providing counseling from board-certified genetics specialists to Cigna members who are at heightened risk for breast cancer, colorectal cancer syndromes, or Long QT syndrome and are considering genetic testing. Such Cigna members will be required to undergo the counseling before having a genetic test done.

"Our approach increases access to genetics specialists who have the training to ensure that every person seeking information about their genetic makeup and health risks receives the best and most personalized information available to get the most appropriate care," InformedDNA CEO David Nixon said in a statement. "This proven model for health care utilization ensures that all Cigna customers have swift access to a board-certified genetics specialist to help them evaluate the potential impact of genetic testing on them and their family members."

Life science investment firm MPM Capital's SunStates Fund earlier this month acquired a minority stake in InformedDNA with a $3 million investment.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.